Astrana Health, Inc.
DE ˙ DB ˙ US03763A2078
32,20 € ↑0,80 (2,55%)
2026-06-05
DEL PRIS
SecurityDE:3AM / Astrana Health, Inc.
InstitutionGeode Capital Management, Llc
Latest Disclosed Ownership1,038,085 shares
Latest Disclosed Value $ 25,458,709
Geode Capital Management, Llc reports 0.96% increase in ownership of 3AM / Astrana Health, Inc.

On May 15, 2026 - Geode Capital Management, Llc filed a 13F-HR form disclosing ownership of 1,038,085 shares of Astrana Health, Inc. (DE:3AM) valued at $21,592,168 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 1,028,168 shares of Astrana Health, Inc.. This represents a change in shares of 0.96% during the quarter. The current value of the position is $33,426,337 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ASTRANA HEALTH COM NEW 03763A207 1,038,085 9,917 0.96 25,459 -0.22 0.0008
2026-02-09 2025-12-31 13F ASTRANA HEALTH COM NEW 03763A207 1,028,168 12,212 1.20 25,513 -11.43 0.0016
2025-11-12 2025-09-30 13F ASTRANA HEALTH COM NEW 03763A207 1,015,956 -37,380 -3.55 28,807 9.90 0.0018
2025-08-08 2025-06-30 13F ASTRANA HEALTH COM NEW 03763A207 1,053,336 -13,805 -1.29 26,210 -20.81 0.0018
2025-05-13 2025-03-31 13F ASTRANA HEALTH COM NEW 03763A207 1,067,141 50,366 4.95 33,099 3.22 0.0026
2025-02-12 2024-12-31 13F ASTRANA HEALTH COM NEW 03763A207 1,016,775 -1,243 -0.12 32,066 -45.65 0.0025
2024-11-12 2024-09-30 13F ASTRANA HEALTH COM NEW 03763A207 1,018,018 2,451 0.24 58,995 43.19 0.0048
2024-08-09 2024-06-30 13F ASTRANA HEALTH COM NEW 03763A207 1,015,567 25,085 2.53 41,199 -0.95 0.0036
2024-05-13 2024-03-31 13F ASTRANA HEALTH COM NEW 03763A207 990,482 46,033 4.87 41,596 14.98 0.0038
2024-02-13 2023-12-31 13F APOLLO MEDICAL HOLDINGS COM NEW 03763A207 944,449 42,278 4.69 36,176 29.97 0.0038
2023-11-13 2023-09-30 13F APOLLO MEDICAL HOLDINGS COM NEW 03763A207 902,171 40,348 4.68 27,835 2.21 0.0033
2023-08-11 2023-06-30 13F APOLLO MEDICAL HOLDINGS COM NEW 03763A207 861,823 74,520 9.47 27,234 -5.15 0.0032
2023-05-15 2023-03-31 13F APOLLO MEDICAL HOLDINGS COM NEW 03763A207 787,303 30,007 3.96 28,713 130,409.09 0.0037
2023-02-13 2022-12-31 13F APOLLO MEDICAL HOLDINGS COM NEW 03763A207 757,296 33,908 4.69 22 -99.92 0.0031
2022-11-14 2022-09-30 13F APOLLO MEDICAL HOLDINGS COM NEW 03763A207 723,388 -8,154 -1.11 28,212 -0.06 0.0043
2022-08-12 2022-06-30 13F APOLLO MEDICAL HOLDINGS COM NEW 03763A207 731,542 27,244 3.87 28,230 -17.30 0.0041
2022-05-13 2022-03-31 13F APOLLO MEDICAL HOLDINGS COM NEW 03763A207 704,298 31,438 4.67 34,137 -30.95 0.0043
2022-02-11 2021-12-31 13F APOLLO MEDICAL HOLDINGS COM NEW 03763A207 672,860 41,218 6.53 49,441 -14.03 0.0060
2021-11-12 2021-09-30 13F APOLLO MEDICAL HOLDINGS COM NEW 03763A207 631,642 169,984 36.82 57,511 98.34 0.0077
2021-08-13 2021-06-30 13F APOLLO MEDICAL HOLDINGS COM NEW 03763A207 461,658 120,947 35.50 28,996 214.18 0.0040
2021-05-12 2021-03-31 13F APOLLO MEDICAL HOLDINGS COM NEW 03763A207 340,711 39,152 12.98 9,229 67.53 0.0014
2021-02-12 2020-12-31 13F APOLLO MEDICAL HOLDINGS COM NEW 03763A207 301,559 6,975 2.37 5,509 4.26 0.0009
2020-11-13 2020-09-30 13F APOLLO MEDICAL HOLDINGS COM NEW 03763A207 294,584 -24,887 -7.79 5,284 0.25 0.0010
2020-08-13 2020-06-30 13F APOLLO MEDICAL HOLDINGS COM NEW 03763A207 319,471 21,803 7.32 5,271 37.09 0.0011
2020-05-14 2020-03-31 13F APOLLO MEDICAL HOLDINGS COM NEW 03763A207 297,668 17,349 6.19 3,845 -25.48 0.0010
2020-02-20 2019-12-31 13F/A-1 APOLLO MEDICAL HOLDINGS COM NEW 03763A207 280,319 -54,646 -16.31 5,160 -12.57 0.0011
2020-02-13 2019-12-31 13F APOLLO MEDICAL HOLDINGS COM NEW 03763A207 280,319 -54,646 5,160 657.5968
2019-11-12 2019-09-30 13F APOLLO MEDICAL HOLDINGS COM NEW 03763A207 334,965 113,526 51.27 5,902 59.51 0.0014
2019-08-14 2019-06-30 13F APOLLO MEDICAL HOLDINGS COM NEW 03763A207 221,439 31,994 16.89 3,700 6.63 0.0009
2019-05-14 2019-03-31 13F APOLLO MEDICAL HOLDINGS COM NEW 03763A207 189,445 6,000 3.27 3,470 -4.70 0.0009
2019-03-06 2018-12-31 13F/A-1 APOLLO MEDICAL HOLDINGS COM NEW 03763A207 183,445 22,917 14.28 3,641 2.80 0.0011
2019-02-13 2018-12-31 13F APOLLO MEDICAL HOLDINGS COM NEW 03763A207 183,445 22,917 3,641
2018-11-13 2018-09-30 13F APOLLO MEDICAL HOLDINGS COM NEW 03763A207 160,528 95,686 147.57 3,542 111.34 0.0010
2018-08-14 2018-06-30 13F APOLLO MEDICAL HOLDINGS COM NEW 03763A207 64,842 64,842 1,676 0.0005
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.